Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of GSK1278863 with Pioglitazone, Rosuvastatin, and Trimethoprim
NCT02371603Phase 1Completed
- Sponsor
- GSK
- Start
- Feb 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of daprodustat in anemia (2 arms), sponsored by GSK. Primary endpoints: Maximum Plasma Concentration at 48 hours and Area Under the Curve at 48 hours. Started Feb 2015; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02371603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371603.